Publishing research using ab54615? Please let us know so that we can cite the reference in this datasheet.

ab54615 has been referenced in 5 publications.

  • Martin GG  et al. Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels. Lipids N/A:N/A (2016). WB ; Mouse . PubMed: 27450559
  • Kaczocha M  et al. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms. Mol Pain 11:52 (2015). WB ; Mouse . PubMed: 26311517
  • Busquets-Garcia A  et al. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med 19:603-7 (2013). WB . PubMed: 23542787
  • Brocato B  et al. Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity. Placenta 34:983-9 (2013). PubMed: 24008071
  • Leung K  et al. Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation. PLoS One 8:e79355 (2013). WB, ICC/IF ; Human . PubMed: 24223930

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"